MTDT

(redirected from Mycobacterium Tuberculosis Direct Test)
AcronymDefinition
MTDTMemory Technology, Design, and Testing (IEEE Workshop)
MTDTMaking the Difference Together (parenting)
MTDTMycobacterium Tuberculosis Direct Test (infectious diseases)
MTDTMathematics Test Development Team (Qualifications and Curriculum Authority; UK)
References in periodicals archive ?
Comparative evaluation of initial and new versions of the Gen-Probe amplified Mycobacterium tuberculosis direct test for direct detection of Mycobacterium tuberculosis in respiratory and non respiratory specimens.
Clinical efficacy of the amplified Mycobacterium tuberculosis direct test for the diagnosis of pulmonary tuberculosis.
Evaluation of Gen-Probe amplified mycobacterium tuberculosis direct test by using respiratory and nonrespiratory specimens in a tertiary care center laboratory.
INDEX TERMS: Molecular Methods, Real-Time PCR, Cepheid GeneXpert, Cepheid SmartCycler, Methicillin-resistant Staph aureus, Mycobacterium tuberculosis, Vancomycin-resistant Enterococcus, COBAS AMPLICOR CT/NG test, AMPLIFIED Mycobacterium tuberculosis Direct Test, FDA cleared assays
The Amplified Mycobacterium tuberculosis Direct Test (MTD, Gen-Probe, San Diego, California) was approved by the Food and Drug Administration (FDA) in 1995 for use with AFB smear-positive respiratory specimens, and in a supplement application, an enhanced MTD test was approved in 1999 for use with AFB smear-negative respiratory specimens from patients suspected to have TB.
tuberculosis o "Mycobacterium tuberculosis direct test" (o MTD, GenProbe).
Misidentification and diagnostic delay caused by a false positive amplified Mycobacterium tuberculosis direct test in an immunocompetent patient with a Mycobacterium celatum infection.
These are the Enhanced Mycobacterium tuberculosis Direct Test (E-MTD; GenProbe, San Diego, CA) and the Amplicor Mycobacterium tuberculosis Test (Amplicor; Roche Diagnostic Systems, Inc., Branchburg, NJ).
To date, the Food and Drug Administration (FDA) has cleared 2 NAA tests for direct detection of MTBC in respiratory specimens, the Amplified Mycobacterium Tuberculosis Direct Test (MTD) (Gen-Probe, Inc, San Diego, Calif) and the AMPLICOR Mycobacterium tuberculosis Test (Roche Diagnostic Systems, Inc, Indianapolis, Ind).
On September 30, 1999, the Food and Drug Administration approved a reformulated Amplified Mycobacterium Tuberculosis Direct Test [*] (MTD) (Gen-Probe(r), San Diego, California) for detection of Mycobacterium tuberculosis in acid-fast bacilli (AFB) smear-positive and smear-negative respiratory specimens from patients suspected of having tuberculosis (TB).
Evaluation of Gen-Probe amplified Mycobacterium tuberculosis direct test and PCR for direct detection of Mycobacterium tuberculosis in clinical specimens.
Amplified mycobacterium tuberculosis direct test for in-vitro diagnostic use: 50 test kit [Package insert].
Full browser ?